Cargando…
Correction: Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection. Vaccines 2019, 7, 72
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157487/ https://www.ncbi.nlm.nih.gov/pubmed/32093400 http://dx.doi.org/10.3390/vaccines8010094 |
| _version_ | 1783522353256333312 |
|---|---|
| author | Cabral-Miranda, Gustavo Lim, Stephanie M. Mohsen, Mona O. Pobelov, Ilya V. Roesti, Elisa S. Heath, Matthew D. Skinner, Murray A. Kramer, Matthias F. Martina, Byron E. E. Bachmann, Martin F. |
| author_facet | Cabral-Miranda, Gustavo Lim, Stephanie M. Mohsen, Mona O. Pobelov, Ilya V. Roesti, Elisa S. Heath, Matthew D. Skinner, Murray A. Kramer, Matthias F. Martina, Byron E. E. Bachmann, Martin F. |
| author_sort | Cabral-Miranda, Gustavo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7157487 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | MDPI |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71574872020-05-01 Correction: Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection. Vaccines 2019, 7, 72 Cabral-Miranda, Gustavo Lim, Stephanie M. Mohsen, Mona O. Pobelov, Ilya V. Roesti, Elisa S. Heath, Matthew D. Skinner, Murray A. Kramer, Matthias F. Martina, Byron E. E. Bachmann, Martin F. Vaccines (Basel) Correction MDPI 2020-02-20 /pmc/articles/PMC7157487/ /pubmed/32093400 http://dx.doi.org/10.3390/vaccines8010094 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Correction Cabral-Miranda, Gustavo Lim, Stephanie M. Mohsen, Mona O. Pobelov, Ilya V. Roesti, Elisa S. Heath, Matthew D. Skinner, Murray A. Kramer, Matthias F. Martina, Byron E. E. Bachmann, Martin F. Correction: Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection. Vaccines 2019, 7, 72 |
| title | Correction: Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection. Vaccines 2019, 7, 72 |
| title_full | Correction: Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection. Vaccines 2019, 7, 72 |
| title_fullStr | Correction: Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection. Vaccines 2019, 7, 72 |
| title_full_unstemmed | Correction: Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection. Vaccines 2019, 7, 72 |
| title_short | Correction: Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection. Vaccines 2019, 7, 72 |
| title_sort | correction: zika virus-derived e-diii protein displayed on immunologically optimized vlps induces neutralizing antibodies without causing enhancement of dengue virus infection. vaccines 2019, 7, 72 |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157487/ https://www.ncbi.nlm.nih.gov/pubmed/32093400 http://dx.doi.org/10.3390/vaccines8010094 |
| work_keys_str_mv | AT cabralmirandagustavo correctionzikavirusderivedediiiproteindisplayedonimmunologicallyoptimizedvlpsinducesneutralizingantibodieswithoutcausingenhancementofdenguevirusinfectionvaccines2019772 AT limstephaniem correctionzikavirusderivedediiiproteindisplayedonimmunologicallyoptimizedvlpsinducesneutralizingantibodieswithoutcausingenhancementofdenguevirusinfectionvaccines2019772 AT mohsenmonao correctionzikavirusderivedediiiproteindisplayedonimmunologicallyoptimizedvlpsinducesneutralizingantibodieswithoutcausingenhancementofdenguevirusinfectionvaccines2019772 AT pobelovilyav correctionzikavirusderivedediiiproteindisplayedonimmunologicallyoptimizedvlpsinducesneutralizingantibodieswithoutcausingenhancementofdenguevirusinfectionvaccines2019772 AT roestielisas correctionzikavirusderivedediiiproteindisplayedonimmunologicallyoptimizedvlpsinducesneutralizingantibodieswithoutcausingenhancementofdenguevirusinfectionvaccines2019772 AT heathmatthewd correctionzikavirusderivedediiiproteindisplayedonimmunologicallyoptimizedvlpsinducesneutralizingantibodieswithoutcausingenhancementofdenguevirusinfectionvaccines2019772 AT skinnermurraya correctionzikavirusderivedediiiproteindisplayedonimmunologicallyoptimizedvlpsinducesneutralizingantibodieswithoutcausingenhancementofdenguevirusinfectionvaccines2019772 AT kramermatthiasf correctionzikavirusderivedediiiproteindisplayedonimmunologicallyoptimizedvlpsinducesneutralizingantibodieswithoutcausingenhancementofdenguevirusinfectionvaccines2019772 AT martinabyronee correctionzikavirusderivedediiiproteindisplayedonimmunologicallyoptimizedvlpsinducesneutralizingantibodieswithoutcausingenhancementofdenguevirusinfectionvaccines2019772 AT bachmannmartinf correctionzikavirusderivedediiiproteindisplayedonimmunologicallyoptimizedvlpsinducesneutralizingantibodieswithoutcausingenhancementofdenguevirusinfectionvaccines2019772 |